Chiron Investment Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,752
| Closed | -$2.12M | – | 87 |
|
|
2024
Q3 | $2.12M | Buy |
+10,752
| New | +$2.12M | 0.75% | 38 |
|
|
2023
Q4 | – | Sell |
-44,625
| Closed | -$6.65M | – | 89 |
|
|
2023
Q3 | $6.65M | Buy |
+44,625
| New | +$6.65M | 2.81% | 12 |
|
|
2023
Q2 | – | Sell |
-223
| Closed | -$35.5K | – | 124 |
|
|
2023
Q1 | $35.5K | Hold |
223
| – | – | 0.01% | 124 |
|
|
2022
Q4 | $36K | Sell |
223
-10,097
| -98% | -$1.63M | 0.01% | 121 |
|
|
2022
Q3 | $1.39M | Buy |
+10,320
| New | +$1.39M | 0.28% | 43 |
|
|
2018
Q3 | – | Sell |
-208,202
| Closed | -$19.3M | – | 70 |
|
|
2018
Q2 | $19.3M | Buy |
208,202
+4,431
| +2% | +$411K | 1.33% | 37 |
|
|
2018
Q1 | $19.3M | Buy |
203,771
+8,285
| +4% | +$784K | 1.68% | 34 |
|
|
2017
Q4 | $18.9M | Buy |
195,486
+73,200
| +60% | +$7.08M | 2.56% | 24 |
|
|
2017
Q3 | $10.9M | Buy |
122,286
+22,685
| +23% | +$2.02M | 2.29% | 19 |
|
|
2017
Q2 | $7.22M | Sell |
99,601
-5,800
| -6% | -$421K | 2.14% | 22 |
|
|
2017
Q1 | $6.87M | Buy |
105,401
+42,800
| +68% | +$2.79M | 2.61% | 17 |
|
|
2016
Q4 | $3.92M | Buy |
+62,601
| New | +$3.92M | 2.72% | 15 |
|